TWC
SEEL

TD Waterhouse Canada’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

TD Waterhouse Canada’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$5 – 2041
2024
Q2 		$5 Buy
+1
New +$34 ﹤0.01% 1904
2024
Q1 		– Sell
-1
Closed -$88 – 1979
2023
Q4 		$88 Hold
1
– – ﹤0.01% 1659
2023
Q3 		$486 Hold
1
– – ﹤0.01% 1596
2023
Q2 		$2.38K Hold
1
– – ﹤0.01% 1518
2023
Q1 		$1.47K Hold
1
– – ﹤0.01% 1555
2022
Q4 		$1.41K Hold
1
– – ﹤0.01% 1530
2022
Q3 		$2.08K Buy
+1
New +$3.93K ﹤0.01% 1504

Other funds holding SEEL

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CHA
Carmichael Hill & Associates Gaithersburg, Maryland $282M AUM 32.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TD Waterhouse Canada's SEEL Position: Q3 2024 in Review

TD Waterhouse Canada sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q3 2024, closing a stake of 1 share — an estimated $5 sold.

TD Waterhouse Canada first reported a position in SEEL in Q3 2022 and held it in 7 quarters. The position peaked at $2.38K in Q2 2023. 15 funds tracked by Wall St. Rank hold SEEL as of Q3 2024.

  • TD Waterhouse Canada reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • TD Waterhouse Canada sold 1 Seelos Therapeutics, Inc. Common Stock share in Q3 2024, an estimated $5.
  • TD Waterhouse Canada first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • TD Waterhouse Canada's Seelos Therapeutics, Inc. Common Stock position peaked at $2.38K in Q2 2023.
  • 15 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2024.

Based on TD Waterhouse Canada's 13F filing for Q3 2024, filed 12 Nov 2024.